I
Disc Medicine D
D
IRON
51.580
USD
1.58
(3.16%)
مغلق
حجم التداول
20,875
الربح لكل سهم
-5
العائد الربحي
-
P/E
-13
حجم السوق
1,786,436,936
الأخبار المقالات
العنوان: Disc Medicine
القطاع: Healthcare
الصناعة: Biotechnology
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.